Bio-Rad Laboratories (BIO) EPS (Diluted) Growth (3y) (2012 - 2026)
Bio-Rad Laboratories (BIO) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | -118.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.52% |
| Dec 31, 2025 | -1.71% |
| Sep 30, 2025 | -32.37% |
| Jun 30, 2025 | 33.44% |
| Mar 31, 2025 | 26.42% |
| Dec 31, 2024 | 21.18% |
| Sep 30, 2024 | -43.58% |
| Jun 30, 2024 | -65.28% |
| Mar 31, 2024 | -25.38% |
| Dec 31, 2023 | -24.74% |
| Sep 30, 2023 | -56.32% |
| Jun 30, 2023 | -47.84% |
| Mar 31, 2023 | -53.27% |
| Dec 31, 2022 | 14.87% |
| Sep 30, 2022 | 14.22% |
| Jun 30, 2022 | -52.74% |
| Mar 31, 2022 | -80.84% |
| Dec 31, 2021 | -23.65% |
| Sep 30, 2021 | 144.51% |
| Jun 30, 2021 | 50.64% |